Ikarian Capital’s Chemomab Therapeutics CMMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $247K | Hold |
53,263
| – | – | 0.05% | 77 |
|
|
2025
Q1 | $232K | Hold |
53,263
| – | – | 0.03% | 92 |
|
|
2024
Q4 | $386K | Sell |
53,263
-85
| -0.2% | -$615 | 0.05% | 92 |
|
|
2024
Q3 | $335K | Hold |
53,348
| – | – | 0.05% | 80 |
|
|
2024
Q2 | $196K | Hold |
53,348
| – | – | 0.03% | 80 |
|
|
2024
Q1 | $166K | Hold |
53,348
| – | – | 0.02% | 74 |
|
|
2023
Q4 | $109K | Hold |
53,348
| – | – | 0.01% | 71 |
|
|
2023
Q3 | $191K | Hold |
53,348
| – | – | 0.02% | 68 |
|
|
2023
Q2 | $280K | Sell |
53,348
-5,829
| -10% | -$30.5K | 0.04% | 67 |
|
|
2023
Q1 | $342K | Sell |
59,177
-19,171
| -24% | -$111K | 0.08% | 73 |
|
|
2022
Q4 | $1M | Buy |
78,348
+16,874
| +27% | +$216K | 0.24% | 38 |
|
|
2022
Q3 | $612K | Sell |
61,474
-5,552
| -8% | -$55.3K | 0.12% | 42 |
|
|
2022
Q2 | $992K | Hold |
67,026
| – | – | 0.18% | 44 |
|
|
2022
Q1 | $1.29M | Buy |
67,026
+710
| +1% | +$13.7K | 0.17% | 58 |
|
|
2021
Q4 | $1.83M | Sell |
66,316
-5,000
| -7% | -$138K | 0.27% | 44 |
|
|
2021
Q3 | $3.16M | Sell |
71,316
-1,318
| -2% | -$58.4K | 0.22% | 48 |
|
|
2021
Q2 | $5.53M | Buy |
+72,634
| New | +$5.53M | 0.45% | 29 |
|